فارماکوجینومک (PGx)

Pharmacogenomic (PGx) testing at EIV Diagnostics analyzes a patient's genetic makeup to predict how they will respond to specific medications. By identifying variants in genes that encode drug-metabolizing enzymes, transporters, and receptors, PGx testing enables providers to select the right drug at the right dose — reducing adverse drug reactions and improving therapeutic outcomes.

Our PGx panels cover key drug-gene interactions across psychiatry, pain management, cardiology, oncology, and primary care. Results are delivered in a clear, clinician-friendly format that maps each variant to actionable prescribing guidance, with reference to CPIC and FDA pharmacogenomic guidelines.

Patients benefit from a personalized approach to medication management, avoiding the costly and potentially dangerous trial-and-error process of traditional prescribing.